Replimune Group Inc
REPL
NASDAQ
Biotechnology
$14.97
USD
-0.22 (-1.45%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.28B
Volume 2.4M
Price Target
$9.00 – $17.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $17.00 and a min estimate of $9.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$13.00
+$11.0 vs prior
Implied Upside
-13.2%
+73.5% vs prior
Analyst Covering
2
-1 vs prior period
Consensus
Hold
Improved vs prior
Signal Quality
Consensus Freshness
40%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
1 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Jonathan Chang | Leerink Partners | Buy | Upgraded | 1 week ago | Plus | Plus | Plus |
Li Watsek | Cantor Fitzgerald | Buy | Upgraded | 2 weeks ago | Plus | Plus | Plus |
Robert Driscoll | Wedbush | Hold | Maintained | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
PURR
Hyperliquid Strategies Inc
$6.68
▼ -2.0%
MNKD
MannKind Corp
$3.85
▲ +3.2%
INBX
Inhibrx Biosciences Inc
$88.37
▼ -8.9%
CGEM
Cullinan Therapeutics Inc
$20.34
▲ +3.6%
NVAX
Novavax Inc
$8.05
▼ -1.1%
SVRA
Savara Inc
$5.38
▲ +2.1%
VOR
Vor Biopharma Inc
$23.03
▼ -1.1%
MGTX
MeiraGTx Holdings PLC
$13.52
▲ +6.7%
CRVS
Corvus Pharmaceuticals Inc
$14.89
▼ -1.6%